← Holdings
BIO-B

Bio-Rad Laboratories, Inc. Class A

2 managers · $40M total
Data: SEC EDGAR 13F · 2026Q2
Manager holders · last 5 qtrs
2
2025Q2 – 2026Q2 · -1 QoQ
Total position
$40M
Combined value across tracked managers
Net move this quarter
↑ Adding
Weighted by holders' share change
HolderQ actionValue% of port.Style
HoskingAdd+36.84%$28M0.92%Contrarian value / Global diversified
MarathonTrim-21.78%$12M0.5%Capital cycle / Contrarian value
Earnings Calls

No earnings call data yet

FinancialsFY2025 · Source: SEC EDGAR 10-K

5y revenue CAGR -3% · latest net margin 29.4% · FCF consistently positive

Revenue$2.58B
Rev. YoY+0.7%
Gross margin51.9%
Net margin29.4%
Net income$0.76B
Free cash flow$0.37B
Operating cash flow$0.53B
ROE10.2%

Source: SEC EDGAR company filings (10-K). Foreign issuers (20-F/IFRS) not yet covered.